Evidence map›Paper›PMID 10225878›Full record

ArticleInfection and immunity1999

Functional expression of Nramp1 in vitro in the murine macrophage line RAW264.7.

G Govoni, F Canonne-Hergaux, C G Pfeifer, S L Marcus, S D Mills, D J Hackam, S Grinstein, D Malo, B B Finlay, P Gros

Open access · bronzeAbstract read
In one paragraph

Article in Infection and immunity, 1999. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 96 citations in OpenAlex.

  1. Review
  2. Article
  3. Human Macrophages Clear the Biovar Microtus Strain ofFrontiers in cellular and infection microbiology · 2019
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Nramp1 and NrampB Contribute to Resistance againstFrontiers in cellular and infection microbiology · 2017
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

G GovoniDepartment of Biochemistry, McGill University, Montreal, Quebec.
F Canonne-Hergaux
C G Pfeifer
S L Marcus
S D Mills
D J Hackam
S Grinstein
D Malo
B B Finlay
P Gros
University of British Columbia · CAMcGill University · CAHospital for Sick Children · CAMontreal General Hospital · CA

Funding

NRAMP1 IN MACROPHAGE DEFENCES AGAINST INFECTIONSR01AI035237 · NIAID · MCGILL UNIVERSITY · PI GROS, PHILIPPE · 1993 to 2015
$2.3M
NRAMPL AND PHAGOCYTE FUNCTIONR21AI035237 · NIAID · MCGILL UNIVERSITY · PI GROS, PHILIPPE · 2000 to 2000
$166k
NIAID NIH HHS AI35237NIAID NIH HHS R01 AI035237NIAID NIH HHS R21 AI035237
6 · The paper itself

Abstract

Mutations at the Nramp1 locus in vivo cause susceptibility to infection by unrelated intracellular microbes. Nramp1 encodes an integral membrane protein abundantly expressed in the endosomal-lysosomal compartment of macrophages and is recruited to the phagosomal membrane following phagocytosis. The mechanism by which Nramp1 affects the biochemical properties of the phagosome to control microbial replication is unknown. To devise an in vitro assay for Nramp1 function, we introduced a wild-type Nramp1(G169) cDNA into RAW 264.7 macrophages (which bear a homozygous mutant Nramp1(D169) allele and thus are permissive to replication of specific intracellular parasites). Recombinant Nramp1 was expressed in a membranous compartment in RAW264.7 cells and was recruited to the membrane of Salmonella typhimurium and Yersinia enterocolitica containing phagosomes. Evaluation of the antibacterial activity of RAW264.7 transfectants showed that expression of the recombinant Nramp1 protein abrogated intracellular replication of S. typhimurium. Studies with a replication-defective S. typhimurium mutant suggest that this occurs through an enhanced bacteriostatic activity. The effect of Nramp1 expression was specific, since (i) it was not seen in RAW264.7 transfectants overexpressing the closely related Nramp2 protein, and (ii) control RAW264.7 cells, Nramp1, and Nramp2 transfectants could all efficiently kill a temperature-sensitive, replication-defective mutant of S. typhimurium. Finally, increased antibacterial activity of the Nramp1 RAW264.7 transfectants was linked to increased phagosomal acidification, a distinguishing feature of primary macrophages expressing a wild-type Nramp1 allele. Together, these results indicate that transfection of Nramp1 cDNAs in the RAW264.7 macrophage cell line can be used as a direct assay to study both Nramp1 function and mechanism of action as well as to identify structure-function relationships in this protein.

Indexed as

Cation Transport ProteinsAllelesAnimalsCarrier ProteinsCell LineDNA, ComplementaryGene ExpressionGenes, mycHydrogen-Ion ConcentrationMacrophagesMembrane ProteinsMiceMutationMycobacterium bovisNatural Resistance-associated Macrophage Protein 1PhagosomesCarrier ProteinsCation Transport ProteinsDNA, ComplementaryMembrane ProteinsNatural Resistance-associated Macrophage Protein 1Recombinant Fusion Proteins

Identifiers

PMID10225878
PMCPMC115961
OpenAlexW2124956156

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.